Research > Focus C
Prof. Dr. med. Stefan M. Pfister
Hopp-Children´s Comprehensive Cancer Center at the NCT Heidelberg, Division of Pediatric Neurooncology, DKFZ Heidelberg
The work packages of Focus C in conjunction with the molecular information of Focus A will provide and expand a diagnostic platform, which is capable of coping with the needs of trialists and clinicians for assessment of heterogeneity, real-time non-invasive assessment of response and resistance and the generation of signatures or footprints allowing for personalized treatments. Further, Focus C will provide central data on a drug and biological repository as well as on different radiation qualities (together with B05) to be used not only in the other work packages but also in further clinical studies. Specific advanced outcomes may be automated glioblastoma MRI diagnostics and integration of metabolic signatures from globally available tissue resources without the need for demanding freezing processes and the potential for developing phase 0 trials.
C01
Hopp-Children´s Comprehensive Cancer Center at the NCT Heidelberg, Division of Pediatric Neurooncology, DKFZ Heidelberg
University Hospital of Heidelberg, Department of Clinical Pharmacology and Pharmacoepidemiology
C02
University Hospital Heidelberg, Department of Neuroradiology
University Hospital Heidelberg, Department of Neuroradiology
C03
PhD, University Hospital Heidelberg, Department of Neuroradiology
C04
Hochschule Mannheim, Center for Mass Spectrometry and Optical Spectroscopy
German Cancer Research Center (DKFZ), Brain Cancer Metabolism Group
C05
University Hospital Heidelberg, Radiationoncology, UKHD
University Hospital Heidelberg, Radiationoncology, UKHD